Accordingly, indisulam-mediated RBM39 depletion by DCAF15 results in altered splicing of HOXA9 target genes, and cytotoxicity in cancers including acute myeloid leukemia (AML)17. This evidence concerns the gene DCAF15 and acute myeloid leukemia.